Altabax - 2007 FDA approvals

Drug: Altabax (retapamulin)
Indication: Impetigo
Company: GlaxoSmithKline
Approval Date: April 12, 2007

Scoop: Altabax is a topical treatment of impetigo, an infection of the top layers of the skin that typically occurs in infants and children 2 to 6 years of age. Altabax is the first new class of prescription topical antibacterials--called pleuromutilins-- which inhibit bacterial protein synthesis and are active against a variety of pathogenic bacteria.

Altabax - 2007 FDA approvals
Read more on

Suggested Articles

Karen DeSalvo's appointment is the latest in a string of hires that deepen the tech giant’s investment in and focus on healthcare.

Spring Bank’s hepatitis B drug, given in tandem with Gilead’s Vemlidy, tamped down on chronic disease in 23% of patients in a phase 2 study.

Verseau will use the money to start testing its macrophage checkpoint modulators in humans.